Cancer Keys: Faecal Calprotectin

Latest from the Blog

Improve the quality of your referral with GatewayC

Improve the quality of your referral with GatewayC

Friday 25th September 2020 Are you seeking to improve your suspected cancer referrals? Our Improving the Quality of Your Referral course aims to assist you with this and covers: Clinical decision making Helping to reduce DNAs Key information to include in a referral...

read more
Cancer Keys: Jaundice and Pancreatic Cancer

Cancer Keys: Jaundice and Pancreatic Cancer

Potential pitfall: Jaundice can be a classic symptom of pancreatic cancer; about half of patients have jaundice when they first go to their GP. Yet, pancreatic cancer is difficult to diagnose as symptoms can vary or may be late, vague and non-specific. Helpful hint:...

read more

Related Posts

Cancer Keys: Jaundice and Pancreatic Cancer

Cancer Keys: Jaundice and Pancreatic Cancer

Potential pitfall: Jaundice can be a classic symptom of pancreatic cancer; about half of patients have jaundice when they first go to their GP. Yet, pancreatic cancer is difficult to diagnose as symptoms can vary or may be late, vague and non-specific. Helpful hint:...

read more
Cancer Keys: Migraines versus Brain Tumours

Cancer Keys: Migraines versus Brain Tumours

Potential pitfall: A migraine headache is typically a unilateral, frontal, throbbing headache which may be associated with photophobia or phonophobia. Although the intensity can vary, the characteristics of the headache tend not to change. Helpful hint: The most...

read more

Potential pitfall:

Faecal calprotectin testing is an incredibly sensitive investigation for detecting the presence of inflammation. It is raised in a wide variety of conditions including malignancy, inflammatory bowel disease and alcohol misuse. It is therefore not good at defining either the site or the cause of inflammation.

Helpful hint:

The NICE DG11 guidance recommends faecal calprotectin testing as an option to support clinicians with the differential diagnosis of inflammatory bowel disease (IBD), or irritable bowel syndrome (IBS), in adults with recent onset lower gastrointestinal symptoms for whom specialist assessment is being considered, if:

    • cancer is not suspected, having considered the risk factors (for example, age) described in the NICE guideline on suspected cancer and
    • appropriate quality assurance processes and locally agreed care pathways are in place for the testing.

Cancer Keys are brought to you by GatewayC.

Download this Cancer Key here

Read the NICE NG12 guidance here

Access GatewayC’s Faecal Immunochemical Test (FIT) course here

LinkedIn Twitter | Facebook